NON-SMALL-CELL LUNG CARCINOMA
Clinical trials for NON-SMALL-CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL-CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL-CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin c boost: could high doses improve lung cancer treatment?
Disease control OngoingThis study tests whether adding high-dose vitamin C (ascorbate) to the usual combination of chemotherapy and radiation helps control non-small cell lung cancer. About 43 participants receive the standard treatment plus high-dose vitamin C. The goal is to see if the tumor shrinks …
Matched conditions: NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Joseph J. Cullen, MD, FACS • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC
-
New drug combo shows promise against tough lung cancer
Disease control OngoingThis study tests an experimental drug called rilvegostomig (AZD2936) in people with advanced or metastatic non-small cell lung cancer (NSCLC) that cannot be removed by surgery. The drug is a bispecific antibody that targets two immune checkpoints (TIGIT and PD-1) to help the immu…
Matched conditions: NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC